Literature DB >> 8328595

Reporting efficiency during a measles outbreak in New York City, 1991.

S F Davis1, P M Strebel, W L Atkinson, L E Markowitz, R W Sutter, K S Scanlon, S Friedman, S C Hadler.   

Abstract

OBJECTIVES: During an epidemic of measles among preschool children in New York City, an investigation was conducted in 12 city hospitals to estimate reporting efficiency of measles to the New York City Department of Health.
METHODS: Measles cases were identified by review of hospital emergency room and infection control logs and health department surveillance records. The Chandra Sekar Deming method was used (1) to estimate the total number of measles cases in persons less than 19 years old who presented to the 12 hospitals from January through March 1991 and (2) to estimate reporting efficiency. Information on mechanisms for reporting measles cases was collected from hospital infection control coordinators.
RESULTS: The Chandra Sekar Deming method estimated that 1487 persons with measles presented to the 12 hospitals during the study period. The overall reporting efficiency was 45% (range = 19% to 83%). All 12 hospitals had passive surveillance for measles; 2 also had an active component. These 2 hospitals had the first and third highest measles reporting efficiencies.
CONCLUSIONS: The reporting efficiency of measles cases by New York City hospitals to the health department was low, indicating that the magnitude of the outbreak was substantially greater than suggested by the number of reported cases.

Entities:  

Mesh:

Year:  1993        PMID: 8328595      PMCID: PMC1694768          DOI: 10.2105/ajph.83.7.1011

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

Review 1.  Epidemiology of measles in the United States in 1989 and 1990.

Authors:  J S Gindler; W L Atkinson; L E Markowitz; S S Hutchins
Journal:  Pediatr Infect Dis J       Date:  1992-10       Impact factor: 2.129

2.  Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination.

Authors:  S L Cochi; L E Edmonds; K Dyer; W L Greaves; J S Marks; E Z Rovira; S R Preblud; W A Orenstein
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

3.  Patterns of transmission in measles outbreaks in the United States, 1985-1986.

Authors:  L E Markowitz; S R Preblud; W A Orenstein; E Z Rovira; N C Adams; C E Hawkins; A R Hinman
Journal:  N Engl J Med       Date:  1989-01-12       Impact factor: 91.245

4.  The epidemiology and natural history of measles in Denmark.

Authors:  O Horwitz; K Grünfeld; B Lysgaard-Hansen; K Kjeldsen
Journal:  Am J Epidemiol       Date:  1974-08       Impact factor: 4.897

5.  The efficiency of measles and pertussis notification in England and Wales.

Authors:  J A Clarkson; P E Fine
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

6.  Measles in Mexico.

Authors:  J Fernandez de Castro
Journal:  Rev Infect Dis       Date:  1983 May-Jun

7.  Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont.

Authors:  R L Vogt; D LaRue; D N Klaucke; D A Jillson
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

8.  A comparison of national infection and immunization estimates for measles and rubella.

Authors:  J A Bean; L F Burmeister; C L Paule; P Isacson
Journal:  Am J Public Health       Date:  1978-12       Impact factor: 9.308

9.  Current features of measles in the United States: feasibility of measles elimination.

Authors:  A R Hinman; A D Brandling-Bennet; R H Bernier; C D Kirby; D L Eddins
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

10.  A controlled trial of disease surveillance strategies.

Authors:  S B Thacker; S Redmond; R B Rothenberg; S B Spitz; K Choi; M C White
Journal:  Am J Prev Med       Date:  1986 Nov-Dec       Impact factor: 5.043

View more
  12 in total

1.  Evaluation of the completeness of reporting of invasive meningococcal disease.

Authors:  P Rivest; B Sagot; L Bédard
Journal:  Can J Public Health       Date:  1999 Jul-Aug

2.  A model for estimating the impact of changes in children's vaccines.

Authors:  K N Simpson; A K Biddle; N R Rabinovich
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

3.  The need for innovation in immunization.

Authors:  P J Edelson
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

4.  Measles reporting completeness during a community-wide epidemic in inner-city Los Angeles.

Authors:  D P Ewert; S Westman; P D Frederick; S H Waterman
Journal:  Public Health Rep       Date:  1995 Mar-Apr       Impact factor: 2.792

5.  The reporting efficiency of measles by hospitals in Los Angeles County, 1986 and 1989.

Authors:  D P Ewert; P D Frederick; G H Run; L Mascola
Journal:  Am J Public Health       Date:  1994-05       Impact factor: 9.308

6.  Completeness of tuberculosis case reporting, San Juan and Caguas Regions, Puerto Rico, 1992.

Authors:  C R Driver; C R Braden; R L Nieves; A M Navarro; J V Rullan; S E Valway; E McCray
Journal:  Public Health Rep       Date:  1996 Mar-Apr       Impact factor: 2.792

7.  Stochastic modeling of empirical time series of childhood infectious diseases data before and after mass vaccination.

Authors:  Helen Trottier; Pierre Philippe; Roch Roy
Journal:  Emerg Themes Epidemiol       Date:  2006-08-08

8.  Anticipating epidemic transitions with imperfect data.

Authors:  Tobias S Brett; Eamon B O'Dea; Éric Marty; Paige B Miller; Andrew W Park; John M Drake; Pejman Rohani
Journal:  PLoS Comput Biol       Date:  2018-06-08       Impact factor: 4.475

9.  Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.

Authors:  Hayley E Jones; Matthew Hickman; Nicky J Welton; Daniela De Angelis; Ross J Harris; A E Ades
Journal:  Am J Epidemiol       Date:  2014-04-11       Impact factor: 4.897

10.  The average cost of measles cases and adverse events following vaccination in industrialised countries.

Authors:  Hélène Carabin; W John Edmunds; Ulla Kou; Susan van den Hof; Van Hung Nguyen
Journal:  BMC Public Health       Date:  2002-09-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.